Wuhan Yzy Biopharma Co., Ltd.
Overview
Wuhan YZY Biopharma Co., Ltd. is a biotechnology company dedicated to developing bispecific antibody (BsAb)-based therapies for the treatment of cancer-associated complications, cancer, and age-related ophthalmologic diseases. Established in 2010, the company has developed a pipeline of seven clinical-stage drug candidates targeting various cancers and eye diseases.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Wuhan Yzy Biopharma Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Wuhan Yzy Biopharma Co., Ltd.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.